{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:31:02Z","timestamp":1793640662879,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803398"],"award-info":[{"award-number":["81803398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG2019-00105-ICMS"],"award-info":[{"award-number":["MYRG2019-00105-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jare.2021.09.002","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T04:33:11Z","timestamp":1631075591000},"page":"1-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3\u03b2 and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease"],"prefix":"10.1016","volume":"34","author":[{"given":"Yaqi","family":"Bian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Oi Lam","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihong","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benqin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon Ming-Yuen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.jare.2021.09.002_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1601-183X.2007.00373.x","article-title":"Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models","volume":"7","author":"Wirths","year":"2008","journal-title":"Genes Brain Behav"},{"issue":"2","key":"10.1016\/j.jare.2021.09.002_b0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-171166","article-title":"Amyloid-mediated cholinergic dysfunction in motor impairment related to Alzheimer's disease","volume":"64","author":"Schirinzi","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.jare.2021.09.002_b0020","first-page":"1365","article-title":"Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease","volume":"134","author":"Shin","year":"1989","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.jare.2021.09.002_b0025","doi-asserted-by":"crossref","first-page":"B209","DOI":"10.1093\/geronj\/46.6.B209","article-title":"The immunohistochemical evidence of amyloid diffuse deposits as a pathological hallmark in Alzheimer's disease","volume":"46","author":"Behrouz","year":"1991","journal-title":"J Gerontol"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer's disease","volume":"34","author":"O'Brien","year":"2011","journal-title":"Annu Rev Neurosci"},{"issue":"10043","key":"10.1016\/j.jare.2021.09.002_b0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jare.2021.09.002_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","article-title":"Tau immunotherapy for Alzheimer's disease","volume":"21","author":"Pedersen","year":"2015","journal-title":"Trends Mol Med"},{"issue":"4-5","key":"10.1016\/j.jare.2021.09.002_b0045","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.neuropharm.2010.04.005","article-title":"Oxidative stress in Alzheimer disease: a possibility for prevention","volume":"59","author":"Bonda","year":"2010","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-018-08523-5","article-title":"Therapeutic approaches to Alzheimer's disease through modulation of NRF2","volume":"21","author":"Bahn","year":"2019","journal-title":"Neuromolecular Med"},{"issue":"31","key":"10.1016\/j.jare.2021.09.002_b0055","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1021\/acs.jafc.8b02607","article-title":"Pinostrobin exerts neuroprotective actions in neurotoxin-induced Parkinson's disease models through Nrf2 induction","volume":"66","author":"Li","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jare.2021.09.002_b0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bbr.2017.09.011","article-title":"Pharmacological activation of the Nrf2 pathway by 3H\u20131, 2-dithiole-3-thione is neuroprotective in a mouse model of Alzheimer disease","volume":"336","author":"Cui","year":"2018","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jare.2021.09.002_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.freeradbiomed.2013.11.014","article-title":"Antisense oligonucleotide against GSK-3beta in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: Involvement of transcription factor Nrf2 and implications for Alzheimer disease","volume":"67","author":"Farr","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2021.09.002_b0070","article-title":"Glycogen synthase kinase 3: a kinase for all pathways?","author":"Patel","year":"2017123277","journal-title":"Curr Top Dev Biol"},{"issue":"2","key":"10.1016\/j.jare.2021.09.002_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1083\/jcb.200505078","article-title":"Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain","volume":"171","author":"Ryan","year":"2005","journal-title":"J Cell Biol"},{"issue":"10","key":"10.1016\/j.jare.2021.09.002_b0080","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.exger.2005.05.007","article-title":"The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease","volume":"40","author":"Butterfield","year":"2005","journal-title":"Exp Gerontol"},{"issue":"5","key":"10.1016\/j.jare.2021.09.002_b0085","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","article-title":"The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice","volume":"84","author":"Farr","year":"2003","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.jare.2021.09.002_b0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.expneurol.2007.05.005","article-title":"Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment","volume":"206","author":"Banks","year":"2007","journal-title":"Exp Neurol"},{"issue":"8","key":"10.1016\/j.jare.2021.09.002_b0095","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1021\/acs.jproteome.6b00152","article-title":"Discovery, synthesis, and functional characterization of a novel neuroprotective natural product from the fruit of Alpinia oxyphylla for use in Parkinson's disease through LC\/MS-based multivariate data analysis-guided fractionation","volume":"15","author":"Li","year":"2016","journal-title":"J Proteome Res"},{"key":"10.1016\/j.jare.2021.09.002_b0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.physbeh.2014.11.016","article-title":"Protective effect of n-butanol extract from Alpinia oxyphylla on learning and memory impairments","volume":"139","author":"Shi","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jare.2021.09.002_b0105","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ejphar.2018.11.002","article-title":"Tectochrysin from Alpinia Oxyphylla Miq. alleviates Abeta1-42 induced learning and memory impairments in mice","volume":"842","author":"He","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0110","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10571-011-9731-0","article-title":"Ethanolic extract of fructus Alpinia oxyphylla protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish","volume":"32","author":"Zhang","year":"2012","journal-title":"Cell Mol Neurobiol"},{"issue":"40","key":"10.1016\/j.jare.2021.09.002_b0115","doi-asserted-by":"crossref","first-page":"11170","DOI":"10.1021\/acs.jafc.0c04031","article-title":"Determination of oxyphylla A enantiomers in the fruits of Alpinia oxyphylla by a chiral high-performance liquid chromatography-multiple reaction monitoring-mass spectrometry method and comparison of their in vivo biological activities","volume":"68","author":"Chen","year":"2020","journal-title":"J Agric Food Chem"},{"issue":"3","key":"10.1016\/j.jare.2021.09.002_b0120","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14336\/AD.2019.0612","article-title":"Oxyphylla A promotes degradation of alpha-synuclein for neuroprotection via activation of immunoproteasome","volume":"11","author":"Zhou","year":"2020","journal-title":"Aging Dis"},{"issue":"4","key":"10.1016\/j.jare.2021.09.002_b0125","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.jare.2021.09.002_b0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3233\/JAD-170045","article-title":"Mouse models of Alzheimer's disease","volume":"57","author":"Esquerda-Canals","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2004.09.019","article-title":"Human apoE targeted replacement mouse lines: h-apoE4 and h-apoE3 mice differ on spatial memory performance and avoidance behavior","volume":"159","author":"Grootendorst","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jare.2021.09.002_b0140","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2010.436","article-title":"Leptin levels and Alzheimer disease","author":"Paz-Filho","year":"2010303151478","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jare.2021.09.002_b0145","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2006.08.017","article-title":"Characterization of amyloid deposition in the APPswe\/PS1dE9 mouse model of Alzheimer disease","volume":"24","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol Dis"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainresbull.2011.11.017","article-title":"Mouse models of Alzheimer's disease","volume":"88","author":"Hall","year":"2012","journal-title":"Brain Res Bull"},{"issue":"1\u20132","key":"10.1016\/j.jare.2021.09.002_b0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1015207429786","article-title":"The SAMP8 mouse: a model of Alzheimer disease?","volume":"3","author":"Morley","year":"2002","journal-title":"Biogerontology"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0031-9384(98)00011-0","article-title":"Behavioral assessment of the senescence-accelerated mouse (SAM P8 and R1)","volume":"64","author":"Markowska","year":"1998","journal-title":"Physiol Behav"},{"issue":"5868","key":"10.1016\/j.jare.2021.09.002_b0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jare.2021.09.002_b0170","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/j.1460-9568.1990.tb00014.x","article-title":"Ibotenate lesions of hippocampus and\/or subiculum: dissociating components of allocentric spatial learning","volume":"2","author":"Morris","year":"1990","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.jare.2021.09.002_b0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bbr.2016.04.026","article-title":"Early onset of behavioral alterations in senescence-accelerated mouse prone 8 (SAMP8)","volume":"308","author":"Yanai","year":"2016","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.jare.2021.09.002_b0180","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1212\/01.WNL.0000138440.39918.0C","article-title":"Motor signs during the course of Alzheimer disease","volume":"63","author":"Scarmeas","year":"2004","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jare.2021.09.002_b0185","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1212\/01.WNL.0000162054.15428.E9","article-title":"Motor signs predict poor outcomes in Alzheimer disease","volume":"64","author":"Scarmeas","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0190","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.09.012","article-title":"LTP and LTD: an embarrassment of riches","volume":"44","author":"Malenka","year":"2004","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.jare.2021.09.002_b0195","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1073\/pnas.0507313103","article-title":"AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice","volume":"103","author":"Chang","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.jare.2021.09.002_b0200","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/01.jnen.0000240468.12543.af","article-title":"Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model","volume":"65","author":"Garcia-Alloza","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"issue":"21","key":"10.1016\/j.jare.2021.09.002_b0205","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.3390\/molecules25214926","article-title":"Attenuation of Nrf2\/Keap1\/ARE in Alzheimer's disease by plant secondary metabolites: a mechanistic review","volume":"25","author":"Fakhri","year":"2020","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.jare.2021.09.002_b0210","doi-asserted-by":"crossref","first-page":"15823","DOI":"10.1074\/jbc.M610708200","article-title":"GSK3 beta activity modifies the localization and function of presenilin 1","volume":"282","author":"Uemura","year":"2007","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.jare.2021.09.002_b0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: a possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hern\u00e1ndez","year":"2010","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.jare.2021.09.002_b0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol Med"},{"issue":"3","key":"10.1016\/j.jare.2021.09.002_b0225","first-page":"1767","article-title":"Galangin decreases p-tau, A(42) and -secretase levels, and suppresses autophagy in okadaic acid-induced PC12 cells via an Akt\/GSK3\/mTOR signaling-dependent mechanism","volume":"19","author":"Huang","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jare.2021.09.002_b0230","article-title":"Discovery of the first dual GSK3 beta inhibitor\/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease","volume":"7","author":"Gameiro","year":"2017","journal-title":"Sci Rep-Uk"},{"issue":"3","key":"10.1016\/j.jare.2021.09.002_b0235","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1471-4159.2009.06208.x","article-title":"The muscarinic M1 receptor activates Nrf2 through a signaling cascade that involves protein kinase C and inhibition of GSK-3beta: connecting neurotransmission with neuroprotection","volume":"110","author":"Espada","year":"2009","journal-title":"J Neurochem"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0240","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10715762.2012.742518","article-title":"Protective effect of puerarin against beta-amyloid-induced oxidative stress in neuronal cultures from rat hippocampus: involvement of the GSK-3beta\/Nrf2 signaling pathway","volume":"47","author":"Zou","year":"2013","journal-title":"Free Radic Res"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0197-4580(03)00117-9","article-title":"Regional NAD(P)H:quinone oxidoreductase activity in Alzheimer's disease","volume":"25","author":"SantaCruz","year":"2004","journal-title":"Neurobiol Aging"},{"issue":"1","key":"10.1016\/j.jare.2021.09.002_b0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/NEN.0b013e31827b5713","article-title":"Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases","volume":"72","author":"Tanji","year":"2013","journal-title":"J Neuropath Exp Neur"},{"issue":"Pt B","key":"10.1016\/j.jare.2021.09.002_b0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2015.07.147","article-title":"Nrf2\u2013a therapeutic target for the treatment of neurodegenerative diseases","volume":"88","author":"Johnson","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"38","key":"10.1016\/j.jare.2021.09.002_b0260","doi-asserted-by":"crossref","first-page":"16505","DOI":"10.1073\/pnas.0908397106","article-title":"Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease","volume":"106","author":"Kanninen","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2021.09.002_b0265","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.579052","article-title":"Neuroprotective potency of saffron against neuropsychiatric diseases, neurodegenerative diseases, and other brain disorders: from bench to bedside","volume":"11","author":"Bian","year":"2020","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jare.2021.09.002_b0270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2174\/1570159X11311040005","article-title":"Natural products as promising drug candidates for the treatment of Alzheimer's disease: molecular mechanism aspect","volume":"11","author":"Ansari","year":"2013","journal-title":"Curr Neuropharmacol"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221001703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123221001703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:50:27Z","timestamp":1761857427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123221001703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":54,"alternative-id":["S2090123221001703"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2021.09.002","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3\u03b2 and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2021.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/).","name":"copyright","label":"Copyright"}]}}